Meera Natarajan

Array ( [id] => 6248767 [patent_doc_number] => 20100137221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'PEPTIDES THAT INTERACT WITH TOPOISOMERASE I AND METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/525216 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17556 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137221.pdf [firstpage_image] =>[orig_patent_app_number] => 12525216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866303 [patent_doc_number] => 20080145362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'ANTIBODY COMBINATION USEFUL FOR TUMOR THERAPY' [patent_app_type] => utility [patent_app_number] => 12/036229 [patent_app_country] => US [patent_app_date] => 2008-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9295 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145362.pdf [firstpage_image] =>[orig_patent_app_number] => 12036229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561801 [patent_doc_number] => 20100272731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'ENGINEERED ANTI-IL-23P19 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/526543 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20191 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272731.pdf [firstpage_image] =>[orig_patent_app_number] => 12526543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445304 [patent_doc_number] => 20100279881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Epitope-mediated antigen prediction' [patent_app_type] => utility [patent_app_number] => 12/525605 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20086 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279881.pdf [firstpage_image] =>[orig_patent_app_number] => 12525605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487398 [patent_doc_number] => 20110236374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'GENETICALLY RECOMBINANT ANTIBODY COMPOSITION CAPABLE OF BINDING SPECIFICALLY TO GANGLIOSIDE GM2' [patent_app_type] => utility [patent_app_number] => 12/524215 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 57630 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236374.pdf [firstpage_image] =>[orig_patent_app_number] => 12524215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718644 [patent_doc_number] => 20080241166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Ligands that bind a receptor' [patent_app_type] => utility [patent_app_number] => 12/006933 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 61272 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241166.pdf [firstpage_image] =>[orig_patent_app_number] => 12006933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549467 [patent_doc_number] => 08324350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Dual-specific IL-1α/IL-1β antibodies' [patent_app_type] => utility [patent_app_number] => 12/006068 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 24 [patent_no_of_words] => 68513 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12006068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823005 [patent_doc_number] => 20080227704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'CXCL13 binding proteins' [patent_app_type] => utility [patent_app_number] => 12/004677 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20502 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227704.pdf [firstpage_image] =>[orig_patent_app_number] => 12004677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845491 [patent_doc_number] => 20080181899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Human antibodies to human delta like ligand 4' [patent_app_type] => utility [patent_app_number] => 12/002245 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15915 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181899.pdf [firstpage_image] =>[orig_patent_app_number] => 12002245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820450 [patent_doc_number] => 20080226635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Antibodies against insulin-like growth factor I receptor and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/001332 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10226 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226635.pdf [firstpage_image] =>[orig_patent_app_number] => 12001332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820535 [patent_doc_number] => 20080226659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/949351 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 28986 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226659.pdf [firstpage_image] =>[orig_patent_app_number] => 11949351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820535 [patent_doc_number] => 20080226659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/949351 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 28986 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226659.pdf [firstpage_image] =>[orig_patent_app_number] => 11949351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820535 [patent_doc_number] => 20080226659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/949351 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 28986 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226659.pdf [firstpage_image] =>[orig_patent_app_number] => 11949351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820535 [patent_doc_number] => 20080226659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/949351 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 28986 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226659.pdf [firstpage_image] =>[orig_patent_app_number] => 11949351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4540978 [patent_doc_number] => 07875705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody' [patent_app_type] => utility [patent_app_number] => 11/946220 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 14746 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875705.pdf [firstpage_image] =>[orig_patent_app_number] => 11946220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807320 [patent_doc_number] => 08444971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'OVR110 antibody compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 12/516397 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 7 [patent_no_of_words] => 49133 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12516397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555401 [patent_doc_number] => 08329873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Bispecific single chain Fv antibody molecules and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/943367 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 22871 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11943367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583828 [patent_doc_number] => 07851455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'MN gene and protein' [patent_app_type] => utility [patent_app_number] => 11/932944 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 32897 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851455.pdf [firstpage_image] =>[orig_patent_app_number] => 11932944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574661 [patent_doc_number] => 07855185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-21 [patent_title] => 'MN gene and protein' [patent_app_type] => utility [patent_app_number] => 11/932997 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 32932 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/855/07855185.pdf [firstpage_image] =>[orig_patent_app_number] => 11932997 [rel_patent_id] =>[rel_patent_doc_number] =>)